| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |